E50 (Etoposide 50 mg)

Pill imprint E50 has been identified as Etoposide 50 mg.

Etoposide is used in the treatment of small cell lung cancer; ovarian cancer; cancer; hodgkin's lymphoma; testicular cancer and belongs to the drug class mitotic inhibitors. There is positive evidence of human fetal risk during pregnancy. Etoposide 50 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for E50 (Etoposide 50 mg)

Etoposide 50 mg E50
Etoposide 50 mg E50
Etoposide
Imprint:
E50
Strength:
50 mg
Color:
Pink
Size:
23.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Mitotic inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-3266
Inactive Ingredients:
citric acid anhydrous
gelatin
glycerin
hypromellose
ferric oxide red
polyethylene glycol
propylene glycol
water
ferrosoferric oxide
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0965 UDL Laboratories Inc
54868-5355 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web4)